Physiology of the vasopressin receptors

被引:61
作者
Maybauer, Marc O. [1 ]
Maybauer, Dirk M. [1 ]
Enkhbaatar, Perenlei [1 ,2 ]
Traber, Daniel L. [1 ,2 ,3 ,4 ]
机构
[1] Univ Texas Med Branch, Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Invest Intens Care Unit, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Neurosci & Cell Biol, Galveston, TX 77555 USA
[4] Shriners Burns Hosp, Dept Anesthesiol, Invest Intens Care Unit, Galveston, TX 77555 USA
关键词
vasopressin (VP); sepsis; V1 receptor agonist; vasopressin; oxytocin (ot); amino acid sequences; hypovolemia; arginine-vasopressin (AVP);
D O I
10.1016/j.bpa.2008.03.003
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This review article summarizes the structure, signalling pathways, and tissue distribution of the vasopressin receptors, V-1 vascular, V-2 renal, V-3 pituitary, and oxytocin receptors, as well as the P-2 class of purinoceptors. The physiological effects of vasopressin on its receptors are described. The future direction with regard to the role of the V-1a receptor in circulatory shock states is discussed; further studies with V-1a receptor agonists are warranted to further develop treatment strategies to reduce mortality in life threatening diseases like septic shock.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 51 条
  • [1] ABBOUD FM, 1990, BLOOD VESSELS, V27, P106
  • [2] International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Boeynaems, Jean-Marie
    Barnard, Eric A.
    Boyer, Jose L.
    Kennedy, Charles
    Knight, Gillian E.
    Fumagalli, Marta
    Gachet, Christian
    Jacobson, Kenneth A.
    Weisman, Gary A.
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 281 - 341
  • [3] NITRIC-OXIDE MAY PARTICIPATE IN V-2 VASOPRESSIN-RECEPTOR-MEDIATED RENAL VASODILATION
    AKI, Y
    TAMAKI, T
    KIYOMOTO, H
    HE, H
    YOSHIDA, H
    IWAO, H
    ABE, Y
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) : 331 - 336
  • [4] Catecholamines and vasopressin during critical illness
    Asfar, P
    Hauser, B
    Radermacher, P
    Matejovic, M
    [J]. CRITICAL CARE CLINICS, 2006, 22 (01) : 131 - +
  • [5] Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia:: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism
    Asfar, P
    Hauser, B
    Iványi, Z
    Ehrmann, U
    Kick, J
    Albicini, M
    Vogt, J
    Wachter, U
    Brückner, UB
    Radermacher, P
    Bracht, H
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (02) : 373 - 380
  • [6] Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats
    Asfar, P
    Pierrot, M
    Veal, N
    Moal, F
    Oberti, F
    Croquet, V
    Douay, O
    Gallois, Y
    Saumet, JL
    Alquier, P
    Calès, P
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 215 - 220
  • [7] Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects
    Bankir, L
    [J]. CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 372 - 390
  • [8] Structural bases of vasopressin/oxytocin receptor function
    Barberis, C
    Mouillac, B
    Durroux, T
    [J]. JOURNAL OF ENDOCRINOLOGY, 1998, 156 (02) : 223 - 229
  • [9] Catecholamines and vasopressin during critical illness
    Bassi, Gabriele
    Radermacher, Peter
    Calzia, Enrico
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2006, 35 (04) : 839 - +
  • [10] Bernat A, 1997, J PHARMACOL EXP THER, V282, P597